Nanocarriers provide a platform to integrate therapy and diagnostics, which is an emerging direction in medical practice. Beyond simply therapeutic functionality, theranostic nanomaterials have been designed to deliver multiple components and imaging agents, facilitating simultaneous and synergistic diagnosis and therapies. In this article, polymeric materials with diverse functionalities and properties for manufacturing theranostic nanomaterials are discussed and compared. We focused on recent advancements in polymeric multifunctional nanomaterials for synergistic theranostics. The drugs and imaging agents were encapsulated within and/or conjugated to the surface of the nanocarriers, according to the fabrication process and carrier type. In parallel with therapy, polymeric multifunctional nanomaterials can be exploited to exhibit distinctive magnetic, electrical, and optical properties for concomitant imaging. This has been accomplished by incorporating various imaging agents, such as fluorescent dyes, biomarkers, quantum dots, metal composites, and magnetic nanoparticles. We discussed theranostic nanomaterial synthesis, carrier fabrication and its applications. By presenting this comprehensive review of the state-of-the-art, we demonstrated that polymeric multifunctional nanomaterials exhibit distinctive advantages and features in theranostics.
Introduction
Nanocarriers provide a platform for theranostics to concurrently realize therapy and diagnosis 1 .
Polymeric drug delivery systems have been widely studied for years. In the 1960s, polymers were mainly utilized for wound healing, blood plasma expanding, and injectable drug releasing 2, 3 . Normally, polymeric nanoparticles are used to deliver drugs to affected tissues and to regulate the release kinetics of the drugs in the body. Prior to treatment, clinical diagnosis is an essential step. Recently, researchers are aiming to achieve diagnosis and therapy in one combined step. Clinicians may monitor drug localization and image the result of the treatment simultaneously after drug administration.
Advances in nanotechnology significantly influenced the treatment and detection of diseases [4] [5] [6] [7] . The strategies used in advanced theranostics, such as polymer conjugations, solid lipid nanoparticles, dendrimers, micelles, magnetic nanoparticles, silica nanoparticles, and quantum dots, may achieve fewer side effects and better synergistic outcomes 8, 9 . The goal of theranostics is to diagnose and treat a disease at its earliest stage. Advanced theranostic nanomedicine possessing multifunctional properties in nature has the ability to diagnose and deliver therapy to the diseased cells with the help of biomarkers and targeting ligands [10] [11] [12] [13] . Conjugation, entrapment, absorption, and encapsulation of drugs and diagnostic agents in polymeric particles can result in combined loading, ultimately achieving the function of theranostics at the molecular and cellular levels [14] [15] [16] .
The therapeutic agents used in theranostic nanomedicine include small chemicals, genetic materials, proteins, and peptides. Imaging techniques that are used in theranostics are mainly dependent on the contrast agent used 17 . As a 2D imaging instrument, gamma scintigraphy is more efficient in visualizing drug localization through pulmonary and oral routes. As a 3D imaging system, positron emission tomography (PET) and single photon emission computed tomography (SPECT) can be used to observe regional depositions of drugs in the lung. However, some practical hurdles limit the clinical application of SPECT and PET 18 . In order to deliver active drugs and imaging agents simultaneously, drug delivery systems (DDS) have been designed to control therapeutic agents' release to treat illnesses and to mark the affected tissues or cells. For specific conditions like hypoxia, the control of pH, temperature, light, and ultrasound has been carried out to precisely regulate the pharmacokinetics of the drugs and imaging agents 19, 20 . Contrast agents in DDS can also be used to monitor the accumulation of particles in tissues and to observe the interactions between the carriers and the microenvironment through a non-invasive way. In this review, we summarize the recent developments in multifunctional polymeric nanomaterial theranostic platforms, for instance drug-polymer conjugates, solid lipid nanoparticles, dendrimers, micelles, magnetic nanoparticles, silica nanoparticles, polymeric/magnetic nanoparticles, polymeric/silica nanoparticles, and quantum dots 21, 22 . We hope that this review can provide a broad overview of the scope of multifunctional polymeric nanomaterials in theranostics.
Drug-polymer conjugates
Polymers with long chain molecules are linked by covalent bonds and can be used to regulate the pharmacokinetics of drugs and/or imaging agents in the body. Drug-polymer conjugates are formed through the connection of various functional groups between the polymer and the drug or imaging agents, (DOTA)- 64 Cu copolymers and evaluated the in vivo tumor localization of theranostic scaffolds by PET.
The RGD sequence enhanced the radioactivity of the copolymer in prostate cancer xenografts from 1.29% ± 0.26% injected dose (ID)/g to 2.75% ± 0.34% ID/g (2.13 fold). The data showed that the copolymer could potentially be used to prepare new nanocarriers for tumor imaging and radiochemotherapy 23 .
Similarly 
Nanoparticles
Nanoparticles are a category of nanoscale carriers based on polymers for drug delivery and diagnosis.
These nanoscale particulates may consist of multiple functional units. They have been extensively employed to control the delivery of encapsulated drugs and imaging agents for both diagnosis and therapy.
Solid lipid nanoparticles
Solid lipid nanoparticles (SLNs) are DDS with improved stability compared with nanoparticles, liposomes, and emulsions. SLNs possess other advantages such as controlled release, targeted delivery, and high loading efficiency while avoiding the use of organic solvents 28, 29 . The dissolved or dispersed drug exists in the solid hydrophobic core, while excipients, including surfactants and phospholipids, are generally recognized as safe for clinical therapy. However, the drawbacks of SLNs, such as size growth, burst release at the earlier stages, tendency of uncontrollable gelation, and dynamics of polymeric transitions, limit their application 30 . Several methods for SLN preparation have been published, including high speed/pressure homogenization 31, 32 , double emulsion 33 , ultrasound dispersion 34 , and use of membrane contactors 35, 36 . Similar to other nanomaterials, SLNs can be used as theranostic formulations to deliver therapeutic and diagnostic agents to targeted sites.
Drugs cannot effectively accumulate in tumor tissues through conventional administration routes. The elementary structure of dendrimers presents a tree-like branched architecture, providing room for a small molecule to be incorporated 41 . Dendrimers, as nanocarriers, have tunable nanoparticle sizes from 10 to 100 nm. They are able to solubilize hydrophobic drugs because of their unique structure. The higher generation dendrimers with a number of branches and cavities are able hold dyes, small molecules, diagnostic agents, and other therapeutics for theranostic applications. Dendrimers were used to load cisplatin for cancer treatment and was proven to have a stronger effect on the malignant cells 42 . The monodispersed macromolecules on the surface of the dendrimers possess a few reactive end groups to modify the properties of the carriers. Weck's group designed a multifunctional dendrimer based on polyamine. The active end groups of the dendrimers included nine amines, nine azides, and 54 acids, connecting with a near-infrared (NIR) cyanine dye. This new material exhibited no toxicity to human glioblastoma cells (T98G) and might be a promising material for theranostics (Fig. 3) 
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. Phthalocyanines are excellent dyes that can be excited to produce near-infrared (NIR) light. This dye is believed to be a theranostic agent to monitor the biodistribution of nanoparticles for the treatment of deep tumors. However, the dye has hydrophobic properties, high aggregation, and low specificity to cancer cells, and therefore, it cannot be used to efficiently treat cancer in clinic applications. Taratula et al. 
Liposomes
Liposomes are small bilayer vesicles with aqueous compartments enclosed by cholesterol and amphiphilic phospholipids. They constitute a nanotechnology-based drug delivery platform and are effective because of their size, characteristics, biodegradability, biocompatibility, immunogenicity, and low toxicity [46] [47] [48] . Liposomes have great potential applications in drug delivery, molecular imaging, vaccine delivery, and gene therapy 16, [49] [50] [51] (Fig. 5 ). The disadvantages of liposomal vesicles are poor stability, low drug-loading efficiency, short circulation time in the blood, and fast drug release Researchers have designed anti-HSP72 gene-transfected stealth immunoliposomes loaded with imaging probes to track themselves by using various types of imaging equipment. The vesicles were further loaded with citicoline to simultaneously improve the symptoms of cerebral ischemia. The data confirmed that the immunoliposomes (80%) were able to accumulate in the peri-infarct region after MRI observation. The lesion volume of rats after the injection of immunoliposomes was up to 30% smaller than that of free citicoline 53 . Wen et al. incorporated apomorphine and quantum dots (QDs) into theranostic liposomes, resulting in decreased accumulation in the liver and increased the distribution in the brain 54 . QDs in the bilayer membrane of the liposomes were used to image the distribution of vesicles in the brain, while the drug in the inner core of the vesicles was used to treat brain disorders. The data confirmed that after liposomal administration, the signal of theranostic liposomes in the animal brain was higher than that of free QDs. The ex vivo imaging of the organs also supported the above-discussed in vivo results. However, the signals in the liver and heart were decreased after liposomal administration.
Apomorphine in the brain was enhanced by 2.4-fold after this incorporation.
Polymeric micelles
Polymeric micelles are self-assembling colloidal structures with a hydrophilic shell and a hydrophobic core. They have properties such as appropriate size range (20-200 nm) for penetrating the blood vessels, high solubility and stability, and long circulation in the body 55 . The strong associations between the polymers and the drug, as well as the conjugation of the polymeric core or of the shell improve the stability of the carriers. The localization of the loaded drug within the particles depends on the properties of the drug, such as polarizability and hydrophobicity. In addition, targeted micelles can prevent premature drug release in the body.
Kim et al. loaded doxorubicin (DOX) into folate-modified micelles and evaluated the therapeutic efficacy of the particles by in vivo studies. The growth of xenografts in nude mice, after administration of drug loaded pH sensitive micelles and non-sensitive micelles, was significantly delayed. However, free DOX was unable to inhibit the growth of tumor volume (an exponential growth curve). Monitoring of both micelles and free drug was carried out by intravital fluorescence microscopy from 0 to 60 min (0, 7, 10, 20, and 60 min). The fluorescence signal of free DOX could be observed from 7 to 60 min. At 60 min, the signal after the administration of the drug-loaded pH-sensitive micelles was still maintained, while that of the blank pH-sensitive micelles began to decrease. In another study, a micelle system used to load cyanine dye and doxorubicin as a novel theranostic platform possessed multiple functionalities such as thermotherapy, near-infrared fluorescence (NIRF) imaging, and synergistic chemotherapy of cytotoxicity from DOX and singlet oxygen from the dye to tumor cells. The results suggested that the micelles were used as a theranostic platform for multi-synergistic therapy and cancer imaging 56 (Fig. 6 ). 
Nanocomposites
Nanocomposites possess multifunctional properties and have many advantages for delivery of drugs and imaging agents. Nanocomposites can be modified with several ligands to achieve the goal of diagnosis, therapy, and entry of carriers across the tissue barrier 57 . The ligands on the surface of nanocomposites enhance the binding affinity of the particles to the targeted cells. In the following part, multifunctional nanocomposites that carrying various targeting moieties for cancer therapy and diagnosis will be discussed.
Polymeric/magnetic nanoparticles
Polymeric/magnetic nanoparticles have been studied as theranostic platforms for various therapies 58 .
Magnetic nanoparticles are composed mainly of iron oxides made from magnetite or hematite 59 .
Magnetic iron oxide nanoparticles have found their way into different fields of medicine and can be synthesized by simple methods, including thermal decomposition and co-precipitation. 
Polymeric/silica nanoparticles
Generally, mesoporous silica nanoparticles (MSNPs) consist of three primary components, including a solid support, a payload of cargo, and external machinery. MSNPs have been investigated as effective drug delivery systems for therapeutic agents against various diseases 69 . It is easy to introduce various functional groups onto the nanoparticles by either electrostatic interactions or covalent bonding, conferring various mechanized features and high versatility to the mesoporous silica materials. As vehicles for the targeted delivery of γ-secretase inhibitors (GSIs), traceable MSNPs were used to block Notch signaling. Cell-specific Notch inhibition improved the premature leakage of the drug during its delivery. In detail, MSNPs loaded with GSIs were coated with polyethylenimine (PEI) and connected with folic acid to target breast cancer cells. The in vivo data showed that the goal of the targeted delivery of MSNPs was realized to some extend (Fig. 8) . Furthermore, most of the nanoparticles were eliminated via the renal pathway after degradation 70 . Fig. 8 The signal intensity of ex vivo organs (liver, kidney, and spleen) and tumors three days after injection of MSNPs. The xenografts were split in half to monitor the distribution of the particles in the tissues (reprinted with permission from ref. 70 ).
In another study, researchers compared the different photodynamic efficacies of silica nanoparticles containing phthalocyanine 4 (Pc4) (Pc4SNPs) and free Pc4 solution. Encapsulation of Pc4 into the polymeric nanoparticles can avoid fluorescent signal quench in the photodynamic therapy, as well as enhance therapeutic efficacy. After encapsulation, the fluorescence spectra and absorption of Pc4SNPs were blue-shifted, and the fluorescence intensity of Pc4SNPs was more enhanced than that of free Pc4 at the same absorbance. LysoTracker Green DND-26 or MitoTracker Green FM was used to mark the lysosomes and mitochondria of A375 and B16F10 cells, as well as colocalize Pc4SNP with these organelles. The results confirmed that compared with free Pc4, Pc4SNPs had higher accumulation in the mitochondria and lysosomes 71 .
Polymeric/gold nanoparticles
Gold nanoparticles (GNS) are versatile platforms that are highly valued as theranostic systems owing to their particular structures and attractive optical properties for photothermal therapy, such as near-infrared absorption, surface enhanced Raman scattering, and localized surface plasmon resonance 72, 73 . The surface of GNS can be effortlessly functionalized with ligands and other functional chemotherapeutics 74 . GNS with core sizes of less than 10 nm provide a large area for ligand modification and drug conjugation. They are usually synthesized using hydrogen tetrachloroaurate and have been widely investigated as drug carriers, radiosensitizers, photothermal converters, and imaging probes in a broad range of applications in cancer diagnosis and therapy 75 . Researchers have shown that GNS have the potential to heighten the efficacy of conventional treatment modalities and are promising tools in diagnostic imaging, minimally invasive thermal ablation therapy, multimodal anti-cancer therapy, and intraoperative tumor margin delineation 76 .
Heo et al. designed GNS functionalized with PEG, biotin, paclitaxel, and dye (rhodamine B)-linked
cyclodextrin derivatives (beta-CD) to undertake therapy and diagnosis simultaneously 77 . As a theranostic platform, beta-CD interacted with paclitaxel and the two formed an inclusion complex. Thereafter, cyclodextrin was connected to the oval GNS with size in the range of 20-40 nm. The in vitro studies indicated that GNS had a stronger targeting efficiency toward cancer cells such as HeLa, A549, and MG63 than toward NIH/3T3 cells. In addition, GNS possess significant cytotoxicity against HeLa cells.
The preliminary study supported that GNS are feasible for use in theranostic nanomedicine. In another study, researchers utilized gold nanosphere（~33 nm）coated with tumor necrosis factor-alpha (Au-TNF) and heated by laser pulses 78 (Fig. 9) . To enhance the photothermal efficiency, the researchers investigated the influence of nanoparticle structure on therapy and diagnosis. A murine carcinoma model was used to compare the therapeutic efficacies of laser with or without Au-TNF conjugates, Au-TNF conjugates alone, laser with TNF-free gold nanospheres, and Au-TNF alone. The results confirmed that the combination of laser with Au-TNF conjugates resulted in a stronger efficacy toward cancer cells.
Currently, the photothermal activation of Au-TNF conjugates is in phase II trial in humans. The Au-TNF conjugates can be combined with clinically relevant nanodrugs to acquire synergistic anti-tumor theranostic action. 
Polymeric/quantum dots
Quantum dots (QDs) were put forward as a new concept in the 1990s 79 . They are nanocrystals made of semiconductor materials and have light-emitting properties that can be optimized by tuning their composition and size. Most QDs are made up of binary alloys of II-VI or III-V semiconductor materials.
QDs are crystalline particles and the size of QDs ranges from 1 to 10 nm. QDs are often encapsulated in an insulating inorganic shell to increase the quantum yield. The coating materials on the surface of the ZnS-capped CdSe QD cores (less than 10 nm) protect it from the microenvironment. It was reported that QD-peptide conjugates accumulated in liver tumors 80 (Fig. 10) . Ex vitro histological results confirmed that the conjugates were able to target cancer in mice, and the PEG coating significantly lowered the reticuloendothelial clearance. However, in vivo detection of the QD signal is challenging. This multifunctional QD system heightened the therapeutic specificity against targeted LNCaP cells. The drug could be tracked by the fluorescence of Dox during its release and transport. 82 In another study, NIR-emitting CdTe QDs (~ 4.5 nm) were synthesized by attaching cyclicRGD (cRGD) peptides to the QDs' surface. In vivo, the margins of tumor and the tumor itself were visualized and distinguished by the resulted QDs. Moreover, the tumor resection was successfully visualized through NIR imaging 83 . Except for the inorganic contrast agents, some dyes also can be used to monitor the pathway of polymeric nanoparticles in vivo. For dyes, the precondition in the clinical application for polymeric nanocomposites is penetration to the deep tissue. Therefore, the dyes which can emit far infrared light are first choice as an imaging marker in the construction of theranostic nanocomposites. Wolfbeis et al.
Polymeric nanoparticles
systematically reviewed the difference between fluorescent nanomaterials and nanoparticles versus molecular fluorophores, labels and probes in the fluorescent bioimaging. Carbon dots, a cluster of carbon atoms have been used to track the kinetics behavior of nanocomposites in vivo. However, the dots with maximum emminsion spectra to 650nm has a lower brightness after the penetration into the deep tissues, thus limiting the application in the lab observation and clinical trials (Fig. 11) 
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Application of theranostic nanomaterials in diseases
The use of nanomaterials in the delivery of drugs or imaging agents 85 has been widely studied.
However, the integration of drugs and imaging agents into one type of nanoparticle-based theranostic platform is a new advance in the past decade 86 . Here, we discuss a wide variety of applications of theranostic nanomaterials in different diseases.
Cancer
Cancer is one of the most challenging clinical problems and is responsible for approximately 13% of all deaths according to the World Health Organization. The complexity of cancer is a major hurdle in the treatment of the disease. Although prognosis is improving, the large variety of cancers and metastases makes treatment very difficult. Regardless of the treatment method, surgery or chemotherapy, visualization of resection or drug transport in the body will reduce relapse and improve the efficacy of chemotherapeutics 87 . Recently, the development of nanoscale theranostic platforms has facilitated the above goals.
Magnetic direction is feasible for targeted drug delivery with the aid of superparamagnetic and magnetic susceptibility. Magnetic nanoparticles can improve the outcomes of clinic therapy and enhance brain tumor-targeted drug delivery. EGFR is highly present within glioblastoma (GBM) tumors. And it may be a promising target for imaging and therapeutic purposes 88 . The wild-type EGFR protein constitutes up to 54% of GBM tumors, while co-overexpression of the wild-type EGFR and its receptor variant III (EGFRvIII) constitutes up to 31% 89 . The specific antibody-modified iron oxide nanoparticles (IONPs) can selectively bind to EGFRvIII on human glioblastoma multiforme (GBM) cells 90 .
Glioblastoma cell survival was significant reduced after administration without significant toxicity to human astrocytes. The level of EGFR phosphorylation was reduced in glioblastoma cells after EGFRvIIIAb-IONP treatment. Convection-enhanced delivery (CED) of EGFRvIIIAb-IONPs directed by MRI promoted the initial distribution of IONPs within or adjacent to the intracranial human xenograft tumors and secondary entry into tumor tissues the following day. CED of magnetic nanoparticles significantly improved the survival of animals that were implanted with the glioblastoma xenografts.
IONPs connected with high-affinity antibodies specific to the EGFRvIII-knockout mutant were able to selectively enhance MRI contrast and accumulated in the infiltrative glioblastoma cells after CED 90 .
Curcumin and bortezomib can inhibit the growth of cancer cells with a synergistic effect but have no anti-osteoclastogenic activity when combined with alendronate (Aln). However, in vivo bioimaging showed that Aln-coated nanoparticles entered bone more easily compared with control groups, promoting bone resorption and inhibiting tumor growth. GNS can offer a stable microenvironment of biomolecules and retain their bioactivity 91 . They are currently being studied for drug delivery to pancreatic cancer cells 92 . GNS-based nanomedicine was named CYT-6091 and was used and observed in advanced cancer patients 93 . The results confirmed that GNS-based nanoparticles were able to significantly reduce the systemic toxicity of chemotherapeutics, an effect that may have been due to the inhibition of an off-target delivery. Eck et al. prepared GNS linked to a heterobifunctional PEG that were conjugated with monoclonal antibodies (mAb F19) to label tumor stroma in thin sections of resected pancreatic adenocarcinoma 94 ( Fig. 12) . Such antibody-conjugated nanoparticles can be used to image pancreatic cancer stroma through selective interaction with fibroblast activation protein (FAP). The images feature d the tissues in dark field microscopy. This theranostic platform may be subjected to clinical application to detect the micrometastasis of pancreatic cancer during surgery. 
Cardiovascular diseases
Cardiovascular diseases (CVDs) encompass a series of conditions, involving vasculature and the heart. Generally speaking, when referring to CVDs, atherosclerotic vascular disease and its sequelae, including myocardial infarction and stroke, are implied 95 . Theranostic strategies for atherosclerotic diseases should significantly improve the therapy of cardiovascular conditions. IONPs have been widely used for imaging applications 59 . This application is very important in atherosclerosis therapy as atherosclerosis is difficult to detect before the presence of clinical symptoms 96 . Lanza's group reported a T1 relaxation effects -weighted (T1w) colloidal iron oxide nanoparticle (CION). This nanoparticle was a cross-linked phospholipid nanoemulsion loaded with oleate-coated magnetite particles. The nanoemulsion reduced T2 relaxation effects, which significant improved positive T1w contrast detection at the nanomolar level 97 . Fumagillin was also loaded into the emulsions containing CIONs 98 ( Fig. 13) . Compared with gadolinium, CIONs could effectively reduce T2 relaxation times and enhance negative contrast. Surprisingly, when CIONs coated with oleic acid were dispersed into almond oil and then entrapped by a mixture of phospholipid surfactants, the effect of T2 was reduced, and these nanoparticles became a highly sensitive T1w contrast agent.
Lopez's group 99 prepared liposomes that recruited activated macrophages because of the metabolically active components from the atheroma tissue. The negatively charged liposomes were loaded with dye (rhodamine), GNS, and lipoprotein-associated phospholipase A2 (LAPA-2). LAPA-2 is an inflammatory biomarker that is highly expressed on activated macrophages. The group confirmed that a high accumulation of liposomes was observed in the shoulder regions of the plaque. They also used transmission electron microscopy to image the localization of lipid vesicles within the atheromas by detecting the GNS. These results supported that the liposomes conjugated with lipoprotein-associated phospholipase A2 can target the metabolically active regions of plaques.
Kidney diseases
Because the kidneys can quickly eliminate particles that are smaller than 10 nm in diameter, it is a candidate organ for the targeted delivery of NPs 100 . However, the kidney cannot excrete a particle with a diameter of greater than 11 nm because of its anatomical structure 101 . Many kidney diseases such as acute renal failure (ARF) and chronic kidney disease (CKD) can be treated by NPs.
For life-threatening ARF, dendrimer NP-based MRI techniques can improve disease detection 102 .
When dendrimers were used to detect ischemia in mice, the data confirmed that the minor increase in the tissue range of the kidney was correlated with the time of ischemia and reperfusion 103 ( Fig. 14) . In sepsis-induced ARF models, studies have confirmed that dendrimers loaded with contrast NPs could detect kidney injury by MRI before the elevation of serum creatinine 104 . This may help eliminate the nephrotoxic elements before kidney damage is detectable in serum. Haick et al. used a non-invasive means to detect end-stage ''renal disease'' using carbon nanotube in a rat model 105. Work was further performed to identify early-stage CKD by using gold NP sensors. Some genetic diseases may cause the development of renal cysts. Mutations in polycystic kidney disease 1 (PKD1) or PKD2 lead to autosomal dominant PKD (ADPKD) in adults clinically. Europium and terbium phosphors were mixed with gadolinium coated on a magnetic core. These theranostic platforms provided strong luminescence and feasibility of magnetic manipulations in the detection of human ADPKD and other genetic diseases 106 . 
Pulmonary diseases
Although the alveoli are very small, together they offer a large total surface area for efficient gas exchange, with a single epithelial cell layer separating air from the capillaries. Meanwhile, the huge surface area can also be used to absorb drugs, nanoparticles, and theranostic agents 
Inflammatory diseases
Inflammatory diseases are involved in the activation of cellular immune response. Macrophages internalize nanoparticles and home to the foci of inflammatory tissues in diseases such as rheumatoid arthritis (RA) and multiple sclerosis (MS) 110 . Macrophages as target cells uptake particles from blood for RA therapy. Researchers have designed RGD-conjugated Au half-shells loaded with methotrexate (MTX) to treat RA. MTX is a first line drug that has been widely used for the treatment of RA 111 . Heat was locally generated by Au half-shells by near-infrared (NIR) irradiation, resulting in enhanced drug release rates and offering thermal therapy and drug treatment to the inflamed joints simultaneously 112 ( Fig. 16 ). 
Neurodegenerative diseases
Neurodegenerative disorders (NDs) such as Parkinson's disease and Alzheimer's disease are characterized with progressive loss of neurons' function and structure 113 . The blood-brain barrier is the main obstacles to prevent the entry of drugs, nanoparticles, and theranostic agents. Certainly, vascular lesions and leakiness of the BBB may provide an opportunity for the penetration of foreign substances into cerebral parenchyma.
Jason et al. confirmed that very small superparamagnetic iron oxide particles (SIOP) can detect lesions in the central nervous system in MS animal models, which cannot be achieved by common MRI contrast agents 114 . Amiri also summarized the advance of magnetic nanoparticles and SIOP as a theranostic system for Alzheimer's disease 115 .
Clinical trials and the commercial market
Polymeric particulate surfaces provide extensive opportunities for the functionalization of drug delivery systems 116, 117 . Multimodal conjugated approaches to the treatment and diagnosis of diseases could improve the efficacy and specificity of treatment regimes. Currently, some nanoscale drug delivery systems such as doxorubicin liposomes (DOXIL Injection) and cytarabine/daunorubicin liposomes (CPX-531 formulation) have entered clinical trials as well as commercial markets [118] [119] [120] . Although nanoscale theranostic platforms can deliver active therapeutics and imaging agents, no currently available 
Conclusion and prospect
Theranostic platforms based on nanomaterials are an emerging area of research integrating targeted delivery and local imaging for diagnosis, which further directs the operation of surgery. Because of the inheritance of techniques from targeted drug delivery, many strategies have been syncretized, such as surface modification, loading process, and tracking drugs in local tissues, which are similar to the loading of therapeutics in nanomaterials. However, there are some differences between loading and tracking due to the combination and properties of the drug and tracking reagents, such as solubility, polarity, sensitivity to oxide, pH condition, humidity, and light. A reasonable fabrication process and loading method should be selected for the protection of drug efficacy and the signal of the imaging reagent. For tracking of imaging agent, the big challenge is to improve the metabolism and decrease the deposition of inorganic materials in the body. Meanwhile, the sensitivity of signal determines the following application of the resulted theranostics in the clinics. The therapeutic effect is based on the targeting efficiency and effective drug accumulation; the diagnostic sensitivity is determined by the type and loading efficiency of bioimaging agent. In addition, unbeneficial interactions of drug chemicals with imaging molecules, such as the complexation, chelation, dye quenching, and drug toxicity, should be avoided. On the other hand, the integration of theranostic platforms should place signal tracking, therapeutic efficacy, and synergistic effects into first priority. Certainly, efforts may need to be made at the end point to achieve specific aims, such as the removal of tumors and localization of thrombi. Researchers should also consider the compatibility of drugs and signal substances, preparation cost, equipment design, and feasibility of industrialization. Meanwhile, the penetration of signal from deep tissues and the discrimination between healthy and abnormal cells would influence the development of theranostic platforms. The chronic toxicity of unspecific drug accumulation and the metabolism of metal particles and fluorescent dyes would encumber clinical applications after translation 125, 126 . Evidently, there is still a long way to go before we can achieve a practical theranostic system based on polymeric multifunctional nanomaterials.
